Evidence map›Paper›PMID 34331350›Full record

ArticleChemistryOpen2021

Synthesis and Antiprotozoal Profile of 3,4,5-Trisubstituted Isoxazoles.

Fernanda Andreia Rosa, Samara Mendes de Souza Melo, Karlos Eduardo Pianoski, Julia Poletto, Mariellen Guilherme Dos Santos, Michael Jackson Vieira da Silva, Danielle Lazarin-Bidóia, Hélito Volpato, Sidnei Moura, Celso Vataru Nakamura

Open access · goldAbstract read
In one paragraph

Article in ChemistryOpen, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Fernanda Andreia RosaDepartamento de Química, Universidade Estadual de Maringá (UEM), Maringá, Brazil.ORCID 0000-0003-0027-7117
Samara Mendes de Souza MeloDepartamento de Química, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
Karlos Eduardo PianoskiDepartamento de Química, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
Julia PolettoDepartamento de Química, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
Mariellen Guilherme Dos SantosDepartamento de Química, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
Michael Jackson Vieira da SilvaDepartamento de Química, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
Danielle Lazarin-BidóiaDepartamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
Hélito VolpatoDepartamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
Sidnei MouraInstituto de Biotecnologia, Universidade de Caxias do Sul (UCS), Caxias do Sul, Brazil.
Celso Vataru NakamuraDepartamento de Ciências Básicas da Saúde, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
Universidade Estadual de Maringá · BRUniversidade de Caxias do Sul · BR

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Fellowship
6 · The paper itself

Abstract

A series of 60 4-aminomethyl 5-aryl-3-substituted isoxazoles were synthesized by an efficient method and evaluated in vitro against Leishmania amazonensis and Trypanosoma cruzi, protozoa that cause the neglected tropical diseases leishmaniasis and Chagas disease, respectively. Thirteen compounds exhibited a selective index greater than 10. The series of 3-N-acylhydrazone isoxazole derivatives bearing the bithiophene core exhibited the best antiparasitic effects.

Indexed as

Antiprotozoal AgentsLeishmaniasisTrypanosoma cruziHumansIsoxazolesStructure-Activity RelationshipAntiprotozoal AgentsIsoxazolesantileishmanial drugsantiprotozoal agentscyclocondensation reactionsisoxazolesN-acylhydrazone derivatives

Identifiers

PMID34331350
PMCPMC8485799
OpenAlexW3186216994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.